Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 4
2007 5
2008 2
2009 5
2010 3
2011 5
2012 1
2013 3
2014 4
2015 3
2016 5
2017 2
2018 3
2019 4
2020 8
2021 2
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
Griewahn L, Müller-Foxworth M, Peintner L, Wissler M, Weiss M, Brauns-Schubert P, Massoumi R, Borner C, Groß O, Yabal M, Charvet C, Maurer U. Griewahn L, et al. Among authors: massoumi r. Cell Rep. 2023 Jan 31;42(1):111961. doi: 10.1016/j.celrep.2022.111961. Epub 2023 Jan 12. Cell Rep. 2023. PMID: 36640323 Free article.
Ubiquitin chain cleavage: CYLD at work.
Massoumi R. Massoumi R. Trends Biochem Sci. 2010 Jul;35(7):392-9. doi: 10.1016/j.tibs.2010.02.007. Epub 2010 Mar 26. Trends Biochem Sci. 2010. PMID: 20347313 Review.
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies.
Zarezadeh Mehrabadi A, Shahba F, Khorramdelazad H, Aghamohammadi N, Karimi M, Bagherzadeh K, Khoshmirsafa M, Massoumi R, Falak R. Zarezadeh Mehrabadi A, et al. Among authors: massoumi r. Crit Rev Oncol Hematol. 2024 Jan;193:104200. doi: 10.1016/j.critrevonc.2023.104200. Epub 2023 Nov 21. Crit Rev Oncol Hematol. 2024. PMID: 37981104 Review.
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.
Shah K, Nasimian A, Ahmed M, Al Ashiri L, Denison L, Sime W, Bendak K, Kolosenko I, Siino V, Levander F, Palm-Apergi C, Massoumi R, Lock RB, Kazi JU. Shah K, et al. Among authors: massoumi r. Blood Cancer J. 2023 Sep 7;13(1):139. doi: 10.1038/s41408-023-00914-7. Blood Cancer J. 2023. PMID: 37679323 Free PMC article.
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.
Grigoryan A, Zacharaki D, Balhuizen A, Côme CR, Garcia AG, Hidalgo Gil D, Frank AK, Aaltonen K, Mañas A, Esfandyari J, Kjellman P, Englund E, Rodriguez C, Sime W, Massoumi R, Kalantari N, Prithiviraj S, Li Y, Dupard SJ, Isaksson H, Madsen CD, Porse BT, Bexell D, Bourgine PE. Grigoryan A, et al. Among authors: massoumi r. Sci Transl Med. 2022 Oct 12;14(666):eabm6391. doi: 10.1126/scitranslmed.abm6391. Epub 2022 Oct 12. Sci Transl Med. 2022. PMID: 36223446
67 results